European Hemostats and Sealants Market by Product (Lyostypt, Sangustop, Tachosil, Avitene, Veriset, and Hemopatch); By Geography (Europe), Industry Trends, Estimation & Forecast, 2018 – 2026

The European Hemostats and Sealants market is expected to reach $84 billion by 2026 growing at a CAGR of 7.9% during the forecast period.

Market Overview

The European Hemostats and Sealants market is expected to reach $84 billion by 2026 growing at a CAGR of 7.9% during the forecast period. Hemostats, sealants, and adhesives are valuable adjuncts to modern surgical procedures. To amplify their benefit, a surgeon needs to understand the safety, usability, efficacy, and cost of these agents.

Market Dynamics

Increasing incidence of chronic diseases, increase in the number of surgeries, and increase in aging population are some of the factors driving the growth of the European hemostats and sealants market. However, stringent regulations, adverse reactions and complications are major hindrances for the market growth. Moreover, increasing number of surgical procedures and the favorable reimbursement scenario in the European region is likely to gain significant impetus for the European hemostats and sealants market share in the coming years.

Market Segmentation

The study provides a crucial view of the European hemostats and sealants by segmenting the market based on the product, and geography. The Product segment includes Lyostypt, Sangustop, Tachosil, Avitene, Veriset, and Hemopatch. Furthermore, geographical coverage has been offered for one of the major regions including Europe.

Scope of the European Hemostats and Sealants Market

By Product
  • Lyostypt
  • Sangustop
  • Tachosil
  • Avitene
  • Veriset
  • Hemopatch
By Geography
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Rest of Europe

TABLE OF CONTENTS Chapter 1 Introduction 1.1 Executive Summary 1.2 Market Definition 1.3 Market Scope Chapter 2 Research Methodology 2.1 Primary Research 2.2 Research Methodology 2.3 Assumptions & Exclusions 2.4 Secondary Data Sources Chapter 3 Market Overview 3.1 Report Segmentation & Scope 3.2 Key Market Trends 3.2.1 Drivers 3.2.2 Restraints 3.2.3 Opportunities 3.3 Porter’s Five Forces Analysis 3.4 Market Share Analysis Chapter 4 European Hemostats and Sealants Market by Product: Market Size and Forecast, 2018 – 2026 4.1 Introduction 4.1.1 Market Size and Forecast 4.2 Lyostypt 4.2.1 Market Size and Forecast 4.3 Sangustop 4.3.1 Market Size and Forecast 4.4 Tachosil 4.4.1 Market Size and Forecast 4.5 Avitene 4.5.1 Market Size and Forecast 4.6 Veriset 4.6.1 Market Size and Forecast 4.7 Hemopatch 4.7.1 Market Size and Forecast Chapter 5 European Hemostats and Sealants Market by Geography: Market Size and Forecast, 2018 – 2026 5.1 Introduction 5.1.1 Market Size and Forecast 5.2 Europe 5.2.1 Europe Market Size and Forecast, By Country 5.2.2 Europe Market Size and Forecast, By Product 5.2.3 UK 5.2.3.1 Market Size and Forecast 5.2.4 Germany 5.2.4.1 Market Size and Forecast 5.2.5 France 5.2.5.1 Market Size and Forecast 5.2.6 Italy 5.2.6.1 Market Size and Forecast 5.2.7 Spain 5.2.7.1 Market Size and Forecast 5.2.8 Rest of Europe 5.2.8.1 Market Size and Forecast Chapter 6 Company Profiles 6.1 B. Braun 6.2 Baxter 6.3 C.R. Bard 6.4 Medtronic 6.5 Takeda

European Hemostats and Sealants Market Key Players
  • Braun
  • Baxter
  • R. Bard
  • Medtronic
  • Takeda

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS